APA (7th ed.) Citation

Y, W., X, S., RX, W., JS, R., HC, L., N, N., & T, L. (2026). Gain-of-Function Variant TRPC6 A404V Is Associated With Doxorubicin-Related Cardiomyopathy. Circulation. Genomic and precision medicine, 19(1), e005334. https://doi.org/10.1161/CIRCGEN.125.005334

Chicago Style (17th ed.) Citation

Y, Wu, Sun X, Wang RX, Reddy JS, Lee HC, Norton N, and Lu T. "Gain-of-Function Variant TRPC6 A404V Is Associated With Doxorubicin-Related Cardiomyopathy." Circulation. Genomic and Precision Medicine 19, no. 1 (2026): e005334. https://doi.org/10.1161/CIRCGEN.125.005334.

MLA (9th ed.) Citation

Y, Wu, et al. "Gain-of-Function Variant TRPC6 A404V Is Associated With Doxorubicin-Related Cardiomyopathy." Circulation. Genomic and Precision Medicine, vol. 19, no. 1, 2026, p. e005334, https://doi.org/10.1161/CIRCGEN.125.005334.